SavedAdd your journal

Journals / The Anatolian Journal of Cardiology / 2019 / Cilt: 22 - Sayı: 4

Mitral valve and right ventricular thrombi possibly caused by heparin-induced thrombocytopenia

Ahmet GÜNER
Anıl AVCI
Abdulkadir USLU
Semih KALKAN
Mehmet ÖZKAN
Pages
206–209
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Heparin-induced thrombocytopenia (HIT) is a devastatingcomplication of heparin treatment that can be associated witharterial and venous thrombosis (1).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Heparin-induced thrombocytopenia (HIT) is a devastatingcomplication of heparin treatment that can be associated witharterial and venous thrombosis (1).
📊
Key Findings & Data:Heparin-induced thrombocytopenia (HIT) is a devastatingcomplication of heparin treatment that can be associated witharterial and venous thrombosis (1).
💡
Conclusion & Impact:Heparin-induced thrombocytopenia (HIT) is a devastatingcomplication of heparin treatment that can be associated witharterial and venous thrombosis (1).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Heparin-induced thrombocytopenia (HIT) is a devastatingcomplication of heparin treatment that can be associated witharterial and venous thrombosis (1).

🔖

Cite This Article

GÜNER, A., AVCI, A., USLU, A., KALKAN, S., ÖZKAN, M. (2019). Mitral valve and right ventricular thrombi possibly caused by heparin-induced thrombocytopenia. The Anatolian Journal of Cardiology, Cilt: 22 - Sayı: 4, 206–209. https://ajindex.com/articles/366680

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Greinacher A. Clinical Practice. Heparin-Induced Thrombocytopenia. N Engl J Med 2015; 373: 252-61
  2. Sachais BS, Rux AH, Cines DB, Yarovoi SV, Garner LI, Watson SP, et al. Rational design and characterization of platelet factor 4 antagonists for the study of heparin-induced thrombocytopenia. Blood 2012; 119: 5955-62
  3. Dasararaju R, Singh N, Mehta A. Heparin induced thrombocytopenia: review. Expert Rev Hematol 2013; 6: 419-28
  4. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003; 76: 2121-31
  5. Warkentin TE, Roberts RS, Hirsh J, Kelton JG. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med 2003; 163: 2518-24
  6. Lee GM, Arepally GM. Heparin-induced thrombocytopenia. Hematology Am Soc Hematol Educ Program 2013; 2013: 668-74
  7. Salter BS, Weiner MM, Trinh MA, Heller J, Evans AS, Adams DH, et al. Heparin-Induced Thrombocytopenia: A Comprehensive Clinical Review. J Am Coll Cardiol 2016; 67: 2519-32
  8. Cuker A. Heparin-induced thrombocytopenia: present and future. J Thromb Thrombolysis 2011; 31: 353-66
  9. Nand S, Wong W, Yuen B, Yetter A, Schmulbach E, Gross Fisher S. Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution. Am J Hematol 1997; 56: 12- 6
  10. Gündüz S, Ozkan M, Biteker M, Duran NE, Güneysu T. Acute myocardial infarction during thrombolysis of mechanical aortic valve thrombosis associated with heparin-induced thrombocytopenia. Clin Appl Thromb Hemost 2011; 17: 283-7
  11. Linkins LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S, et al. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl): e495Se530S
  12. Kang M, Alahmadi M, Sawh S, Kovacs MJ, Lazo-Langner A. Fondaparinux for the treatment of suspected heparin induced thrombocytopenia: a propensity score matched study. Blood 2015; 125: 924-9
  13. Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 2003; 121: 535–55.